Study Purpose:
The purpose of this study is to determine whether a physiological process known as oxidative stress has any impact on the rate of disease progression in sporadic PLS.Study Status:
Not recruiting
Disease:
Primary Lateral Sclerosis (PLS)
Study Type:
Observational
Type of Intervention:
N/A
Intervention Name:
N/A
Placebo:
N/A
Phase:
N/A
Study Chair(s)/Principal Investigator(s):
Hiroshi Mitsumoto, MD (Columbia University)
Clinicaltrials.gov ID:
Neals Affiliated?
No
Coordinating Center Contact Information
The Eleanor and Lou Gehrig MDA/ALS Research Center
Jonathan Hupf / (212) 342-0949
710 West 168th Street, NI 9th Floor
New York, New York, 10032 United States
Full Study Summary:
Study Sponsor:
Spastic Paraplegia Foundation
Estimated Enrollment:
50
Estimated Study Start Date:
11 / 02 / 2016
Estimated Study Completion Date:
11 / 02 / 2016
Posting Last Modified Date:
01 / 31 / 2016
Date Study Added to neals.org:
08 / 02 / 2012
Minimum Age:
20
Inclusion Criteria:Diagnosis of definite sporadic PLS.
At least 5 years and no more than 15 years since symptom onset.
Age: 20 years or older.
Speaks English.
If the patient has had testing for HSP, the results were normal.
Record of recent EMG done within the last 12 months. If not, patient must be willing to have an EMG done for diagnostic purposes.
Must have a reliable caregiver willing to participate (family member or good friend).
Exclusion Criteria:
History of any other major neurological problems.
Any other unstable medical diseases that required treatment in the past 6 months.
Participating in any drug trials before baseline specimens collected.
University of Kansas Medical Center
Maureen Walsh / (913) 588- 0645
Kansas City, Kansas
66160
United States
University of Kentucky
Debby Taylor / (859) 257-5560
Lexington, Kentucky
40536
United States
University of Texas Southwestern
Nina Gorham / (214) 648-0462
Dallas, Texas
75390-8897
United States
Western University London, Ontario
Christine Piechowicz / (519) 685-8500 x34858
London, Ontario
N6A 5A5
Canada